2304: Identifying optimal multiple sclerosis (MS)-specific atrophy markers as primary endpoint for Phase II s in progressive MS

OBJECTIVES/SPECIFIC AIMS: To identify brain regions with the highest and least variable rate of multiple sclerosis (MS)-specific atrophy using an agnostic approach, and to perform simulation-based sample size calculations for Phase II s using these regions as primary endpoint. METHODS/STUDY POPULATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Azevedo, Christina, Cen, Steven, Zheng, Ling, Amirhossein Jaberzadeh, Pelletier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2018
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798701/
http://dx.doi.org/10.1017/cts.2017.127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798701/
http://dx.doi.org/10.1017/cts.2017.127

Ejemplares similares